- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder (Urothelial, Transitional Cell) Cancer
Total 10643 results
-
Shanghai Zhongshan HospitalFudan University; Shanghai Jiao Tong University School of MedicineCompletedUrothelial Carcinoma
-
RemeGen Co., Ltd.Completed
-
The Netherlands Cancer Institute4SC AGActive, not recruitingUrothelial CarcinomaNetherlands
-
Matthew GalskyAstraZenecaActive, not recruitingUrothelial CarcinomaUnited States
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
Genentech, Inc.Approved for marketing
-
Bristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteEndo PharmaceuticalsCompletedUrothelial CarcinomaUnited States
-
Rambam Health Care CampusCompleted
-
National Taiwan University HospitalUnknownUrothelial CarcinomaTaiwan
-
China Medical University HospitalUnknown
-
China Medical University HospitalUnknown
-
National Cancer Institute (NCI)CompletedKidney Neoplasms | Urinary Bladder Neoplasms | Urothelial Carcinoma | Urethral NeoplasmsUnited States
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
Medical University of South CarolinaTerminated
-
Fox Chase Cancer CenterTemple UniversityActive, not recruitingUrothelial CarcinomaUnited States
-
Tianjin Medical University Second HospitalRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisSuspendedClear Cell Renal Cell Carcinoma | Head and Neck Cancer | Gastric Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Biliary Tract Cancer | Urothelial Bladder Cancer | Gastro-oesophageal Adenocarcinoma | Platinum-sensitive Urothelial Bladder CancerFrance
-
M.D. Anderson Cancer CenterActive, not recruitingMalignant Solid Neoplasm | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Metastatic Melanoma | Stage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Unresectable Melanoma | Clinical Stage III Cutaneous... and other conditionsUnited States
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruiting
-
Centre Francois BaclessePfizerRecruiting
-
University of MichiganCompletedUrinary Tract Urothelial CarcinomaUnited States
-
AstraZenecaCompletedBladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer | Transitional Cell Bladder CancerUnited States, Spain, United Kingdom, Germany, Canada
-
UroGen Pharma Ltd.WithdrawnCarcinoma | Transitional Cell Carcinoma | Transitional Cell Cancer of the Renal Pelvis and UreterIsrael, United States
-
Matthew GalskyGenentech, Inc.CompletedUrothelial/Bladder Cancer, NosUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
University of Michigan Rogel Cancer CenterCelgene CorporationTerminatedBladder Cancer | Urothelial CancerUnited States
-
University of MiamiTerminatedBladder Cancer | Bladder Carcinoma | Muscle Invasive Bladder Carcinoma | Transition Cell CancerUnited States
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingSolid Tumor | Urothelial CarcinomaChina
-
M.D. Anderson Cancer CenterRecruitingMetastatic MalignancyUnited States
-
Qinghua Xia,ProfNot yet recruiting
-
Monika Joshi, MDPfizer; Eisai Inc.; Big Ten Cancer Research ConsortiumTerminatedMetastatic Urothelial Cell CancerUnited States
-
Apexigen America, Inc.CompletedMelanoma | Cancer | Head and Neck Cancer | NSCLC | Urothelial Carcinoma | MSI-HUnited States
-
CG Oncology, Inc.TerminatedCarcinoma in Situ | Transitional Cell Carcinoma | Bladder Cancer | Carcinoma in Situ Concurrent With Papillary TumorsUnited States
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Seth LernerAstraZeneca; Cytogen CorporationCompletedUrinary Bladder NeoplasmsUnited States, Italy
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineWithdrawnBladder Cancer | Urothelial CancerUnited States
-
BeiGeneCompletedLocally Advanced or Metastatic Urothelial Bladder CancerKorea, Republic of, China
-
Achieve Life SciencesCompletedCarcinoma, Transitional Cell | Ureteral Neoplasms | Urethral Neoplasms | Bladder NeoplasmsUnited States
-
Asan Medical CenterKorean Cancer Study GroupUnknownTransitional Cell Carcinoma | Bladder Cancer | Ureter CancerKorea, Republic of
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Korea, Republic of, France, Israel, Spain, Italy, United Kingdom, Belgium, Netherlands, Germany
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Urothelial Carcinoma | Myeloproliferative DisorderUnited States
-
Ruijin HospitalHangzhou Genetron Medical Laboratory Co., Ltd.Recruiting
-
Inovio PharmaceuticalsActive, not recruitingUrothelial CarcinomaUnited States
-
National Taiwan University HospitalUnknown
-
University of Alabama at BirminghamBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedUrothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)United States
-
LanZhou UniversityCompleted